Skip to content

Effect of infusion of tranexamic acid at different drip rates on the incidence of nausea and vomiting in patients undergoing posterior scoliosis orthopaedic fusion for adolescent idiopathic scoliosis: a prospective, double-blind, randomised controlled clinical study protocol

Effect of infusion of tranexamic acid at different drip rates on the incidence of nausea and vomiting in patients undergoing posterior scoliosis orthopaedic fusion for adolescent idiopathic scoliosis: a prospective, double-blind, randomised controlled clinical study protocol

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107188
Enrollment
Unknown
Registered
2025-08-06
Start date
2025-09-02
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent idiopathic scoliosis

Interventions

Low-speed group:Tranexamic acid was infused intravenously at 20-31 drops/min using an infusion pump 6h after surgery in patients with AIS.
Medium speed group:Tranexamic acid was infused intravenously using an infusion pump at 32-43 drops/min for 6h postoperatively in patients with AIS.
normal speed group:Tranexamic acid was infused intravenously at 44-55 drops/min using an infusion pump 6h after surgery in patients with AIS.

Sponsors

West China Tianfu Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed with adolescent idiopathic scoliosis and underwent PSS; 2. That the patient is >= 4 and <= 18 years of age; 3. The patient does not have any haematological disorders; 4. The patient agrees to participate in this study and signs the relevant informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patient is allergic to TXA; 2. Patient has hepatic and renal insufficiency; 3. Patient has a history of thrombosis; 4. Patient's age 18 years old; 5. Patients with severe cardiovascular and cerebrovascular and other underlying diseases not suitable for surgery; 6. Those with intraoperative dural injuries that produce cerebrospinal fluid leakage; 7. Patients and their families refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
nausea;vomiting;

Secondary

MeasureTime frame
Electrolyte profile (sodium potassium magnesium calcium chloride);Postoperative blood loss;Hospitalisation satisfaction;Incidence of VTE;Postoperative drainage;

Countries

China

Contacts

Public ContactLiu Li

Sichuan University West China Tianfu Hospital

liuli_guke@163.com+86 189 8060 6109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026